共 177 条
[1]
Wang CW(2009)Usefulness of p16 for differentiating primary pulmonary squamous cell carcinoma from cervical squamous cell carcinoma metastatic to the lung Am J Clin Pathol 131 715-722
[2]
Wu TI(2011)Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma Eur J Obstet Gynecol Reprod Biol 159 394-398
[3]
Yu CT(2014)Improved survival with bevacizumab in advanced cervical cancer N Engl J Med 370 734-743
[4]
Hashimoto K(2016)Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study Gynecol Oncol Res Pract 3 4-1524
[5]
Yonemori K(2011)Survival data from a phase II, open-label study of pazopanib or lapatinib monotherapy in patients with advanced and recurrent cervical cancer J Clin Oncol 29 4845-425
[6]
Katsumata N(2015)Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial Lancet Oncol 16 1515-65
[7]
Tewari KS(2017)A phase 2 study of nanoparticle albumin-bound paclitaxel plus nedaplatin for patients with advanced, recurrent, or metastatic cervical carcinoma Cancer 123 420-904
[8]
Sill MW(2018)A phase I evaluation of extended field radiation therapy with concomitant cisplatin chemotherapy followed by paclitaxel and carboplatin chemotherapy in women with cervical carcinoma metastatic to the para-aortic lymph nodes: an NRG Oncology/Gynecologic Oncology Group study Gynecol Oncol 37 61-286
[9]
Long HJ(2017)Cervical cancer patient-derived orthotopic xenograft (PDOX) is sensitive to cisplatinum and resistant to Nab-paclitaxel Anticancer Res 13 901-995
[10]
Minion LE(1993)A metastatic-orthotopic transplant nude mouse model of human patient breast cancer Anticancer Res 13 283-1052